How Bloom Is Turning Gut Science Into Personalized Nutrition — One Microbiome at a Time

The Organ Medicine Forgot to Personalize

You've tried the elimination diets. You've bought the probiotics off the shelf — the ones with the cheerful green labels promising "gut health support." You've cut gluten, then dairy, then FODMAPs, keeping a food journal that maps your suffering in obsessive detail. And yet the bloating comes back. The fatigue lingers. Your skin flares at seemingly random intervals, and your doctor shrugs and says, "It could be stress."

This isn't a failure of willpower. It's a failure of information. The standard of care for gut-related conditions — IBS, SIBO, leaky gut, chronic inflammation — hasn't meaningfully evolved in decades, despite an explosion of microbiome research that is quietly rewriting what we understand about human health. The problem is a translation gap: the science exists, but it never makes it to your plate.

Bloom was built to close that gap.

What Bloom Does: Your Gut, Sequenced and Fed

Bloom is a personalized gut nutrition platform that combines shotgun metagenomic sequencing with AI-generated meal planning to shift your microbiome composition toward measurably better health. It's not a supplement company. It's not a generic "gut health" app. It's the bridge between what genomic science knows about your microbiome and what you actually eat for dinner.

Here's how it works: You collect a stool sample using Bloom's at-home kit and mail it to the lab. Unlike most consumer microbiome tests that use 16S rRNA sequencing — a cheaper method that can only identify bacteria at the genus level — Bloom uses shotgun metagenomic sequencing, which reads the entire genetic content of your microbiome sample. This means strain-level resolution. Two people might both have Lactobacillus acidophilus present, but at different strains with completely different functional roles in inflammation, serotonin production, and immune regulation. That difference matters enormously. Bloom is built to see it.

From your microbiome profile, Bloom's platform generates a rolling personalized meal plan engineered to feed your specific beneficial bacterial strains — and starve the inflammatory ones you have in excess. Not through restriction or expensive supplement stacks, but through strategic inclusion of prebiotic fibers, fermented foods, and polyphenol-rich ingredients calibrated to your unique gut ecosystem. Think of it as precision fertilizer for a very complicated garden.

Who Bloom Is For

Bloom is built for people who've fallen through the cracks of conventional medicine — the patients whose labs come back "normal" but who feel anything but. More specifically:

• IBS and IBD sufferers who are tired of symptom management and want root-cause answers about their inflammatory microbiome composition
• People with chronic fatigue, brain fog, or mood disorders who have begun to suspect the gut-brain axis is involved and want to test the hypothesis with real data
• Individuals with skin conditions — eczema, psoriasis, acne — increasingly linked in dermatological research to microbiome dysbiosis
• Metabolic health seekers optimizing for blood sugar regulation, weight management, and long-term cardiovascular risk reduction
• Preventive health advocates — the quantified-self crowd who already wear CGMs and track HRV, for whom microbiome sequencing is the obvious next layer
• Oncology adjacent patients — growing research suggests microbiome composition affects immunotherapy response, and patients navigating cancer treatment are increasingly looking for evidence-based nutritional adjuncts

The common thread: these are people who read the science, distrust surface-level wellness marketing, and want their interventions to be actually personalized to their biology — not a generic protocol dressed up with their first name in the subject line.

The Science That Makes Bloom Different

Bloom's scientific foundation is not aspirational — it's operational. The platform is built by a team with direct roots in the Human Microbiome Project, the landmark NIH research initiative that first systematically mapped the human microbiome at scale. The science team includes microbiome researchers, registered dietitians, and food scientists whose specific job is to translate genomic output into recipes a home cook can actually execute on a Tuesday night.

"The gut isn't just a digestive organ. It's a garden. Bloom helps you grow the right things."

The key technical differentiator is the sequencing method. Shotgun metagenomics sequences all the DNA in your sample — bacterial, viral, fungal — and reconstructs complete genetic profiles of each organism present. This allows Bloom to identify not just which bacterial genera are present, but which strains, at what relative abundances, and critically: what metabolites they're producing. Are your bacteria making short-chain fatty acids that protect your intestinal lining? Are they producing lipopolysaccharides that trigger systemic inflammation? Are you low in the specific Akkermansia muciniphila strains associated with metabolic protection? Bloom can tell you. And then it tells you what to eat about it.

The Market Opportunity: A Science Revolution Looking for a Product

The global gut health market is projected to reach $75 billion by 2030, growing at roughly 8% annually. But that number understates the real opportunity, because it's mostly measuring yesterday's products — fiber supplements, probiotic capsules, kombucha — rather than the precision nutrition category that microbiome science is creating from scratch.

The deeper trend is the convergence of three forces that make right now a uniquely compelling moment for Bloom:

1. Sequencing cost collapse: The cost of whole-genome sequencing has dropped by a factor of 1,000 since the Human Genome Project. Shotgun metagenomics, once a research-only tool, is now commercially deployable at consumer-viable price points.
2. Research velocity: PubMed citations for "gut microbiome" have grown more than 10x in the past decade. The clinical evidence base linking specific microbiome signatures to disease states is hitting a critical mass that makes actionable guidance possible.
3. Consumer readiness: Post-pandemic, consumer interest in preventive health, immune function, and personalized medicine is at an all-time high. The customer who buys a CGM is ready to buy a microbiome sequencing kit.

Bloom isn't competing in the crowded probiotic aisle. It's creating a new category: prescription-grade nutrition intelligence at consumer scale. The closest analogs — genetic testing companies like 23andMe, CGM platforms like Levels, or functional medicine practices — each capture a slice of this customer but none connect the sequencing data directly to food in the way Bloom does.

Built in a Flash, Built to Last

Bloom was conceived and launched using Artha, the AI platform that builds and deploys complete companies from a single prompt. What would have taken months of product design, copywriting, technical architecture, and brand development was compressed into a fraction of that timeline — allowing the Bloom team to focus on what they do best: the science.

The Artha platform handled everything from brand positioning and landing page architecture to the product narrative and go-to-market framing. The result is a company that feels deeply considered — because the AI behind it was trained to think like a founder, a marketer, and a product strategist simultaneously. Bloom's tagline, "What's growing inside you matters more than what you eat," didn't come from a six-week branding sprint. It came from a system that understood the product deeply enough to say something true about it.

What's Growing Next

The roadmap for Bloom extends well beyond the initial consumer product. The longitudinal data asset that Bloom builds — microbiome profiles correlated with dietary interventions and health outcomes, collected over time across a large user base — is one of the most scientifically valuable datasets that doesn't yet exist at scale.

Near-term, Bloom is building toward a practitioner-facing product: a clinical dashboard that allows functional medicine doctors, gastroenterologists, and registered dietitians to order Bloom sequencing for patients and receive structured reports they can actually act on. This is a fundamentally underserved market — practitioners who believe in microbiome science but have no clinical tool that speaks their language.

Longer term, the platform positions Bloom squarely at the intersection of personalized nutrition and digital therapeutics. As the evidence base for microbiome-targeted dietary interventions accumulates within Bloom's own dataset, the company has a credible path toward clinically validated protocols — and potentially toward the kind of regulatory recognition that turns a wellness product into a medical one.

The gut is the last great frontier of personalized medicine. Bloom is planting its flag there — not with a supplement, not with a vague wellness claim, but with research-grade genomics and food that tastes good. The garden metaphor in their mission isn't accidental: healthy things take time to grow, but they grow exponentially once the conditions are right.

Build Your Own Company on Artha

Bloom is one of hundreds of companies being built and launched on Artha — the AI platform that turns a founder's vision into a live, positioned, market-ready company from a single prompt. Whether you're a scientist with an idea, an operator with a thesis, or a builder with a problem you refuse to leave unsolved, Artha compresses the distance between insight and launch.

Your company deserves to exist. Artha helps it happen.

👉 Start building at artha.run — and see what grows.